MEDIA
Latest News
Revance is a biotechnology company focused on innovative aesthetic and therapeutic offerings, as well as financial technology services for aesthetic practices.
Main Menu
- 21 April 2022
Revance Therapeutics (RVNC) Announces FDA Acceptance of BLA Resubmission for DaxibotulinumtoxinA for Injection for Glabellar Lines)
- 21 April 2022
Revance Receives FDA Acceptance of BLA Resubmission for DaxiboutlinumtoxinA for Glabellar Lines
- 18 April 2022
How Beauty Innovations Are Approved Here and Abroad – Plus the Global Game Changers Doctors are Buzzing About
- 05 April 2022
Here’s How Deep Products and In-Office Treatments Really Penetrate the Skin
- 20 January 2022